Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project-Reference-Cited by-同舟云学术

Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project

Published:2017-09 Issue: Volume:111 Page:143-149
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bubendorf Lukas,Dafni Urania,Schöbel Martin,Finn Stephen P.,Tischler Verena,Sejda Aleksandra,Marchetti Antonio,Thunnissen Erik,Verbeken Eric K.,Warth Arne,Sansano Irene,Cheney Richard,Speel Ernst Jan M.,Nonaka Daisuke,Monkhorst Kim,Hager Henrik,Martorell Miguel,Savic Spasenija,Kerr Keith M.,Tan Qiang,Tsourti Zoi,Geiger Thomas R.,Kammler Roswitha,Schulze Katja,Das-Gupta Ashis,Shames David,Peters Solange,Stahel Rolf A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J. Cancer,2001

2. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol.,2011

3. Chipping away at the lung cancer genome;Pao;Nat. Med.,2012

4. The introduction of systematic genomic testing for patients with non-small-cell lung cancer;Cardarella;J. Thorac. Oncol.,2012

5. Targeting MET in cancer: rationale and progress;Gherardi;Nat. Rev. Cancer,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Savolitinib conferred sensitivity in a patient with D1228H mutation-induced capmatinib-resistant MET exon 14 skipping mutated lung adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2024-08-24

2. Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging;American Journal of Surgical Pathology;2024-07-08

3. Prediction of MET Overexpression in Lung Adenocarcinoma from Hematoxylin and Eosin Images;The American Journal of Pathology;2024-06

4. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice;Experimental Hematology & Oncology;2024-03-01

5. Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence;JCO Precision Oncology;2024-02